Heart and Vascular Research
Champion-AF Study
AGE: 18 years and older
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
SEX AT BIRTH: All
HEALTHY PARTICIPANTS: No
TYPE: Interventional Treatment Study
CONDITION: Atrial Fibrillation, Stroke
CONDITION: Atrial Fibrillation, Stroke
LOCATION: University Hospitals Cleveland Medical Center
Learn More About This Research Study
For more information, please contact study coordinator, Amy McKnight, RN, BSN, BCCV at 216-983-4896 and leave a message or complete the online form below.
Study Purpose
The purpose of this research study is to determine if left atrial appendage closure with the WATCHMAN FLX device is a reasonable alternative to non-vitamin K oral anticoagulants in patients with non-valvular atrial fibrillation.
Who Can Participate
Individuals who are 18 years and older and have documented non-valvular atrial fibrillation and has a calculated CHA2DS2-VASc score of 2 or greater for men and 3 or greater for women may be eligible for this study.